← Back to Search

CoPILOT Training for Cognitive Impairment (CoPILOT Trial)

Phase 1
Waitlist Available
Led By William C Miller, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be physically able to operate a powered wheelchair joystick
Have sustained a spinal cord injury
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-randomization), 5 weeks (immediate post-intervention)
Awards & highlights

CoPILOT Trial Summary

This trial will test whether a new method of training people with cognitive impairments to use powered wheelchairs is more effective than the standard method. The new method, called CoPILOT, involves using a shared control wheelchair.

Who is the study for?
This trial is for individuals who can physically use a powered wheelchair joystick, have suffered a spinal cord injury, and have mild to moderate cognitive impairment. They should be new to using powered wheelchairs or previously denied one due to learning difficulties from cognitive impairments.Check my eligibility
What is being tested?
The study tests the CoPILOT training method against standard care in teaching people with cognitive challenges how to use power wheelchairs. It involves occupational therapist-led sessions using either shared control wheelchairs or conventional training methods.See study design
What are the potential side effects?
Since this trial focuses on training methods rather than medication, traditional side effects are not applicable. However, participants may experience frustration or fatigue during the learning process.

CoPILOT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can use a powered wheelchair joystick.
Select...
I have had a spinal cord injury.
Select...
I am new to using powered wheelchairs or was previously denied one due to learning difficulties.

CoPILOT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-randomization), 5 weeks (immediate post-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-randomization), 5 weeks (immediate post-intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Power-mobility Indoor Driving Assessment (PIDA)
Secondary outcome measures
Change in Health Utility Index Mark 3 (HUI3)
Change in The Wheelchair Outcome Measure (WhOM)
Change in Wheelchair Skills Test Questionnaire (WST-P-Q)
+3 more

CoPILOT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CoPILOTExperimental Treatment1 Intervention
Experimental group participants will receive structured training in a standard powered wheelchair using the CoPILOT shared control wheelchair technology consisting of 12 hours total training time (one hour, four times per week for three weeks).
Group II: Standard of CareActive Control1 Intervention
Standard of care participants will receive training according to the standard of care in rehabilitation facilities in the Vancouver area in a standard powered wheelchair, consisting of 12 hour protocols in a standard power wheelchair (one hour, four times per week for three weeks).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CoPILOT
2016
N/A
~30

Find a Location

Who is running the clinical trial?

Networks of Centres of Excellence of CanadaOTHER
3 Previous Clinical Trials
568 Total Patients Enrolled
Rick Hansen FoundationOTHER
6 Previous Clinical Trials
115 Total Patients Enrolled
Alzheimer Society of CanadaOTHER
7 Previous Clinical Trials
2,567 Total Patients Enrolled

Media Library

CoPILOT Clinical Trial Eligibility Overview. Trial Name: NCT02320786 — Phase 1
Mild Cognitive Impairment Research Study Groups: Standard of Care, CoPILOT
Mild Cognitive Impairment Clinical Trial 2023: CoPILOT Highlights & Side Effects. Trial Name: NCT02320786 — Phase 1
CoPILOT 2023 Treatment Timeline for Medical Study. Trial Name: NCT02320786 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants presently being enrolled for this experiment?

"This clinical trial is no longer open for recruitment, with the original posting and last update occuring on October 1st 2016 and May 25th 2018 respectively. However, there are an abundance of other trials that prospective participants may consider; in this moment 918 different studies have active enrolment processes."

Answered by AI

Are there any potential dangers associated with the CoPILOT treatment?

"Limited data exists to attest to CoPILOT's safety and efficacy, so it was rated a 1 on our assessment scale."

Answered by AI
~1 spots leftby Mar 2025